Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-22 Purchase |
2021-06-24 4:16 pm |
ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director |
4,666 | $15 | $69,990 | 4,666 (Direct) |
View |
2021-06-22 Purchase |
2021-06-24 4:16 pm |
ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director |
4,666 | $15 | $69,990 | 4,666 (Direct) |
View |
2021-06-22 Purchase |
2021-06-24 4:16 pm |
ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Presight II LP 10% Owner |
700,000 | $15 | $10,500,000 | 21,372,304 (Indirect) |
View |
2021-06-22 Purchase |
2021-06-24 4:16 pm |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
3,500 | $15 | $52,500 | 3,500 (Indirect) |
View |
2021-06-22 Purchase |
2021-06-24 4:15 pm |
ATAI Life Sciences N.V. | ATAI | de Rosnay Alexis Director |
4,666 | $15 | $69,990 | 4,666 (Direct) |
View |
2021-06-22 Purchase |
2021-06-24 4:15 pm |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
2,333 | $15 | $34,995 | 2,333 (Indirect) |
View |
2021-06-22 Purchase |
2021-06-24 4:15 pm |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
700,000 | $15 | $10,500,000 | 21,372,304 (Indirect) |
View |
2021-06-22 Purchase |
2021-06-24 4:15 pm |
ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director |
4,666 | $15 | $69,990 | 5,564,474 (Indirect) |
View |
2021-06-22 Purchase |
2021-06-24 4:15 pm |
ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer |
4,666 | $15 | $69,990 | 4,666 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-03-02 Option Award |
2022-03-04 4:04 pm |
N/A 2032-03-01 |
ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer |
206,950 | $0 | 206,950 (Direct) |
View |
2022-03-02 Option Award |
2022-03-04 3:56 pm |
N/A 2025-08-20 |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
2,666,648 | $0 | 2,666,648 (Direct) |
View |
2022-03-02 Option Award |
2022-03-04 3:56 pm |
N/A 2032-03-01 |
ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer |
228,000 | $0 | 228,000 (Direct) |
View |
2022-03-02 Option Award |
2022-03-04 3:53 pm |
N/A 2032-03-01 |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
649,050 | $0 | 649,050 (Direct) |
View |
2021-12-24 Option Award(A) |
2022-03-04 3:49 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
Ownership |
2022-02-28 9:00 pm |
N/A N/A |
COMPASS Pathways plc | CMPS | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner |
0 | $0 | 9,565,774 (Indirect) |
View |
2022-01-14 Other |
2022-01-19 4:30 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director |
5,559,808 | $0 | 6,084,116 (Indirect) |
View |
2021-12-24 Option Award |
2021-12-28 5:42 pm |
N/A 2031-12-23 |
ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer |
325,000 | $0 | 325,000 (Direct) |
View |
2021-09-10 Option Award |
2021-09-13 4:31 pm |
N/A 2031-09-10 |
ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director |
128,000 | $0 | 128,000 (Direct) |
View |
2021-09-10 Option Award |
2021-09-13 4:30 pm |
N/A 2031-09-10 |
ATAI Life Sciences N.V. | ATAI | Camm Jason Director |
128,000 | $0 | 128,000 (Direct) |
View |
2021-09-10 Option Award |
2021-09-13 4:30 pm |
N/A 2031-09-10 |
ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director |
128,000 | $0 | 128,000 (Direct) |
View |
2021-09-10 Option Award |
2021-09-13 4:30 pm |
N/A 2031-09-10 |
ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director |
128,000 | $0 | 128,000 (Direct) |
View |
2021-09-10 Option Award |
2021-09-13 4:30 pm |
N/A 2031-09-10 |
ATAI Life Sciences N.V. | ATAI | de Rosnay Alexis Director |
128,000 | $0 | 128,000 (Direct) |
View |
2021-09-10 Option Award |
2021-09-13 4:30 pm |
N/A 2031-09-10 |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
128,000 | $0 | 128,000 (Direct) |
View |
2021-09-10 Option Award |
2021-09-13 4:30 pm |
N/A 2031-09-10 |
ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director |
128,000 | $0 | 128,000 (Direct) |
View |
Ownership(A) |
2021-08-25 4:00 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Presight II LP 10% Owner |
0 | $0 | 30,172,400 (Indirect) |
View |
Ownership(A) |
2021-08-25 4:00 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
0 | $0 | 30,172,400 (Indirect) |
View |
2021-06-17 Option Award |
2021-06-22 4:20 pm |
N/A 2031-06-17 |
ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer |
67,726 | $0 | 67,726 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 4:15 pm |
N/A 2031-06-17 |
ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer |
752,311 | $0 | 752,311 (Direct) |
View |
Ownership |
2021-06-17 6:21 pm |
N/A N/A |
ATAI Life Sciences B.V. | ATAI | Auerbach Michael Director |
0 | $0 | 5,559,808 (Indirect) |
View |
Ownership |
2021-06-17 6:19 pm |
N/A 2025-08-21 |
ATAI Life Sciences B.V. | ATAI | Brand Florian See Remarks |
0 | $0 | 4,800,000 (Direct) |
View |
Ownership |
2021-06-17 6:18 pm |
N/A N/A |
ATAI Life Sciences B.V. | ATAI | Apeiron Investment Group Ltd. Presight II LP 10% Owner |
0 | $0 | 28,992,304 (Indirect) |
View |
Ownership |
2021-06-17 6:13 pm |
N/A N/A |
ATAI Life Sciences B.V. | ATAI | Angermayer Christian Director 10% Owner |
0 | $0 | 28,992,304 (Indirect) |
View |